Safety, reactogenicity and immunogenicity of Francisella tularensis live vaccine strain in humans
Hana M. El Sahly(Baylor College of Medicine), W Keitel(Baylor College of Medicine), Mei‐Fong Ho(Center for Devices and Radiological Health), Janet Wells(Baylor College of Medicine), Shital M. Patel(Baylor College of Medicine), Marcela F. Pasetti(University of Maryland Global Campus), T. R. Cate(Baylor College of Medicine), K. Guo(Emmes (United States)), Robert L. Atmar(Baylor College of Medicine), D E Lewis(Baylor College of Medicine), Marcelo B. Sztein(University of Maryland, Baltimore)
Cited by 49
Related Papers
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase
|New England Journal of Medicine|2021|661
Serum Levels of the Proinflammatory Cytokines Interleukin-1 Beta (IL-1β), IL-6, IL-8, IL-10, Tumor Necrosis Factor Alpha, and IL-12(p70) in Malian Children with Severe<i>Plasmodium falciparum</i>Malaria and Matched Uncomplicated Malaria or Healthy Controls
|Infection and Immunity|2004|447
The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters
|The FASEB Journal|2012|395
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road
|Nature Reviews Microbiology|2007|372